Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Giebeler, Arne ^a   Streetz, Konrad L ^a   Soehnlein, Oliver ^c   Neumann, Ulf ^a   Wang, Ji Ming ^d   Brandenburg, Lars Ove ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CD11B ANTIGEN; CXCL1 CHEMOKINE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR 2; INTERLEUKIN 6; KI 67 ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; FORMYL PEPTIDE RECEPTOR 2, MOUSE; FPR1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENOTYPE; HEPATITIS; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; LIVER INJURY; MOUSE; NICK END LABELING; NONHUMAN; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; ENZYME IMMUNOASSAY; GENETICS; INFLAMMATION; INJURIES; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, FORMYL PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84903524933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100522     Document Type: Article

References (53)

1. Friedman SL (2008) Hepatic fibrosis - overview. Toxicology 254: 120-129.
2. Friedman SL (2010) Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 7: 425-436.
3. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115: 209-218. (Pubitemid 40385459)
4. Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Invest 123: 1887-1901.
5. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
6. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
7. Schiffmann E, Corcoran BA, Wahl SM (1975) N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 72: 1059-1062.
8. Carp H (1982) Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 155: 264-275.
9. Schiffmann E, Showell HV, Corcoran BA, Ward PA, Smith E, et al. (1975) The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 114: 1831-1837.
10. Gao JL, Chen H, Filie JD, Kozak CA, Murphy PM (1998) Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51: 270-276. (Pubitemid 28395033)
11. Durstin M, Gao JL, Tiffany HL, McDermott D, Murphy PM (1994) Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem Biophys Res Commun 201: 174-179. (Pubitemid 24213710)
12. He HQ, Liao D, Wang ZG, Wang ZL, Zhou HC, et al. (2013) Functional characterization of three mouse formyl peptide receptors. Mol Pharmacol 83: 389-398.
13. Craig PM, Territo MC, Karnes WE, Walsh JH (1992) Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 33: 1020-1023.
14. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, et al. (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366.
15. Becker EL, Forouhar FA, Grunnet ML, Boulay F, Tardif M, et al. (1998) Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res 292: 129-135. (Pubitemid 28143884)
16. McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, et al. (1995) N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med 182: 207-217.
17. Liberles SD, Horowitz LF, Kuang D, Contos JJ, Wilson KL, et al. (2009) Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ. Proc Natl Acad Sci U S A 106: 9842-9847.
18. Liang TS, Wang JM, Murphy PM, Gao JL (2000) Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils. Biochem Biophys Res Commun 270: 331-335. (Pubitemid 30446837)
19. Cattaneo F, Guerra G, Ammendola R (2010) Expression and signaling of formyl-peptide receptors in the brain. Neurochem Res 35: 2018-2026.
20. Brenner DA (2009) Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 120: 361-368.
21. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332. (Pubitemid 350073596)
22. Giebeler A, Brandenburg LO, Kaldenbach M, Erschfeld S, Wasmuth H, et al. (2012) Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation. Lab Invest 92: 1726-1737.
23. Waechter V, Schmid M, Herova M, Weber A, Gunther V, et al. (2012) Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages. J Immunol 188: 1856-1867.
24. Gao JL, Lee EJ, Murphy PM (1999) Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 189: 657-662. (Pubitemid 29193366)
25. Chen K, Le Y, Liu Y, Gong W, Ying G, et al. (2010) A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J Immunol 184: 3331-3335.
26. Slowik A, Merres J, Elfgen A, Jansen S, Mohr F, et al. (2012) Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells. Mol Neurodegener 7: 55.
27. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, et al. (2008) Characterization of time-related changes after experimental bile duct ligation. Br J Surg 95: 646-656.
28. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J (2005) Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 33: 73-84. (Pubitemid 40127646)
29. Le Y, Yang Y, Cui Y, Yazawa H, Gong W, et al. (2002) Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2: 1-13. (Pubitemid 33086799)
30. Brandenburg LO, Koch T, Sievers J, Lucius R (2007) Internalization of PrP106-126 by the formyl-peptide-receptor-like-1 in glial cells. J Neurochem 101: 718-728. (Pubitemid 46633309)
31. Brandenburg LO, Konrad M, Wruck CJ, Koch T, Lucius R, et al. (2010) Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. J Neurochem 113: 749-760.
32. Lee RJ, Lujan DE, Hall AL, Sklar LA, Wilson BS, et al. (1997) Cooperation between the Fc epsilonR1 and formyl peptide receptor signaling pathways in RBL(FPR) cells: the contribution of receptor-specific Ca2+ mobilization responses. Biochem Biophys Res Commun 235: 812-819. (Pubitemid 27326567)
33. McLeish KR, Knall C, Ward RA, Gerwins P, Coxon PY, et al. (1998) Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J Leukoc Biol 64: 537-545. (Pubitemid 28455400)
34. Wantha S, Alard JE, Megens RT, van der Does AM, Doring Y, et al. (2013) Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res 112: 792-801.
35. Grommes J, Drechsler M, Soehnlein O (2013) CCR5 and FPR1 Mediate Neutrophil Recruitment in Endotoxin-Induced Lung Injury. J Innate Immun.
36. Norling LV, Perretti M (2013) Control of myeloid cell trafficking in resolution. J Innate Immun 5: 367-376.
37. Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, et al. (2009) c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 137: 297-308, 308 e291-294.
38. Zhao Y, Difrancesca D, Wang X, Zarnegar R, Michalopoulos GK, et al. (2007) Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement. J Cell Physiol 213: 556-563. (Pubitemid 47509739)
39. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, et al. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274: 1379-1383. (Pubitemid 26391463)
40. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, et al. (2001) Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276: 26605-26613.
41. Selzner M, Camargo CA, Clavien PA (1999) Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 30: 469-475. (Pubitemid 29357513)
42. Klein C, Wustefeld T, Assmus U, Roskams T, Rose-John S, et al. (2005) The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115: 860-869. (Pubitemid 40489390)
43. Kim SD, Kim JM, Jo SH, Lee HY, Lee SY, et al. (2009) Functional expression of formyl peptide receptor family in human NK cells. J Immunol 183: 5511-5517.
44. Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, et al. (2013) Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 123: 443-454.
45. Stefanovic L, Brenner DA, Stefanovic B (2005) Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med (Maywood) 230: 573-586. (Pubitemid 41233157)
46. Nagaoka I, Tamura H, Hirata M (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176: 3044-3052.
47. Christenson K, Bjorkman L, Tangemo C, Bylund J (2008) Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J Leukoc Biol 83: 139-148.
48. Mukhopadhyay B, Cinar R, Yin S, Liu J, Tam J, et al. (2011) Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. Proc Natl Acad Sci U S A 108: 6323-6328.
49. Mukhopadhyay B, Liu J, Osei-Hyiaman D, Godlewski G, Mukhopadhyay P, et al. (2010) Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J Biol Chem 285: 19002-19011.
50. Aliberti J, Sher A (2002) Positive and negative regulation of pathogen induced dendritic cell function by G-protein coupled receptors. Mol Immunol 38: 891-893. (Pubitemid 34496947)
51. Shin MK, Jang YH, Yoo HJ, Kang DW, Park MH, et al. (2011) N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow. J Biol Chem 286: 17133-17143.
52. Best J, Dolle L, Manka P, Coombes J, van Grunsven LA, et al. (2013) Role of liver progenitors in acute liver injury. Front Physiol 4: 258.
53. Michalopoulos GK (2010) Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 176: 2-13.